Kazia Therapeutics Limited (NASDAQ: KZIA) Stock Information | RedChip

Kazia Therapeutics Limited (NASDAQ: KZIA) Listen to this Section

$0.39
+0.0070 ( +1.82% ) 502.6K

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.

Market Data

Open

$0.39

Previous close

$0.39

Volume

502.6K

Market cap

$11.92M

Day range

$0.37 - $0.42

52 week range

$0.19 - $1.58

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings

Form Type Description Pages Date
6-k Quarterly Reports 1 Jan 12, 2024
6-k Quarterly Reports 12 Dec 06, 2023
6-k Quarterly Reports 2 Dec 01, 2023
6-k Quarterly Reports 4 Nov 29, 2023
6-k Quarterly Reports 5 Nov 29, 2023
6-k Quarterly Reports 3 Nov 21, 2023
6-k Quarterly Reports 2 Nov 20, 2023
6-k Quarterly Reports 4 Nov 15, 2023
6-k Quarterly Reports 3 Nov 14, 2023
6-k Quarterly Reports 3 Nov 01, 2023

Latest News

Terms and Agreement

Please agree to the terms to continue using the chat feature.

About US

Services

Stay Connected